Regulation and function of NF-kappaB transcription factors in the immune system.
暂无分享,去创建一个
[1] A. Mikecz. The nuclear ubiquitin-proteasome system. , 2006 .
[2] G. Baier,et al. Protein Kinase C (cid:2) Affects Ca 2 (cid:3) Mobilization and NFAT Cell Activation in Primary Mouse T Cells , 2022 .
[3] R. Wange,et al. ZAP-70 and SLP-76 Regulate Protein Kinase C-θ and NF-κB Activation in Response to Engagement of CD3 and CD28 , 2001, The Journal of Immunology.
[4] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[5] T. Nakahata,et al. From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only. , 2004 .
[6] E. Kieff,et al. Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Israël,et al. Combined deficiency in IκBα and IκBϵ reveals a critical window of NF-κB activity in natural killer cell differentiation , 2004 .
[8] S. Ghosh,et al. Antigen-Receptor Signaling to Nuclear Factor κB , 2006 .
[9] M. Karin,et al. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.
[10] L. Staudt,et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. , 2007, Cancer cell.
[11] Hong-shan Wang,et al. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells , 2002, Nature Immunology.
[12] J. Ninomiya-Tsuji,et al. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway , 1999, Nature.
[13] M. Karin,et al. IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiation , 2008, Proceedings of the National Academy of Sciences.
[14] J. Ting,et al. Cutting Edge: Monarch-1 Suppresses Non-Canonical NF-κB Activation and p52-Dependent Chemokine Expression in Monocytes1 , 2007, The Journal of Immunology.
[15] R. Gaynor,et al. Role of the TAB2‐related protein TAB3 in IL‐1 and TNF signaling , 2003, The EMBO journal.
[16] S. Foster,et al. Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2 , 2003, The Journal of Biological Chemistry.
[17] E. Harhaj,et al. NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .
[18] P. Galle,et al. Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD , 2007, The Journal of experimental medicine.
[19] David Baltimore,et al. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism , 1986, Cell.
[20] A. Israël. NF-κB activation: nondegradative ubiquitination implicates NEMO , 2006 .
[21] M. Morimatsu,et al. MAIL, a novel nuclear IκB protein that potentiates LPS‐induced IL‐6 production , 2000 .
[22] A. Altman,et al. Antigen-induced translocation of PKC-θ to membrane rafts is required for T cell activation , 2001, Nature Immunology.
[23] J. Caamaño,et al. Regulation of secondary lymphoid organ development by the nuclear factor‐κB signal transduction pathway , 2003, Immunological reviews.
[24] A. Ciechanover,et al. Mechanism of processing of the NF-κB2 p100 precursor: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase , 2004, Oncogene.
[25] Malay Mandal,et al. Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia , 2007, Nature Medicine.
[26] I. Wilson,et al. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[27] M. Karin,et al. The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .
[28] A. Hoffmann,et al. The I (cid:1) B –NF-(cid:1) B Signaling Module: Temporal Control and Selective Gene Activation , 2022 .
[29] T. Deerinck,et al. Abnormal Morphogenesis But Intact IKK Activation in Mice Lacking the IKKα Subunit of IκB Kinase , 1999 .
[30] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[31] S. Akira,et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IκBζ , 2004, Nature.
[32] Xiaodong Wang,et al. A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death , 2004, Science.
[33] C. Wijmenga,et al. The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes , 2003, Nature.
[34] R. Geleziunas,et al. Restoration of NF-κB Activation by Tumor Necrosis Factor Alpha Receptor Complex-Targeted MEKK3 in Receptor-Interacting Protein-Deficient Cells , 2004, Molecular and Cellular Biology.
[35] T. Muta,et al. Positive and Negative Regulation of Nuclear Factor-κB-mediated Transcription by IκB-ζ, an Inducible Nuclear Protein* , 2005, Journal of Biological Chemistry.
[36] Eric Vivier,et al. Functions of natural killer cells , 2008, Nature Immunology.
[37] Brian D. Strahl,et al. A nucleosomal function for IκB kinase-α in NF-κB-dependent gene expression , 2003, Nature.
[38] David Baltimore,et al. One Nucleotide in a κB Site Can Determine Cofactor Specificity for NF-κB Dimers , 2004, Cell.
[39] R. Tibbetts,et al. Molecular Linkage Between the Kinase ATM and NF-κB Signaling in Response to Genotoxic Stimuli , 2006, Science.
[40] S. Klauck,et al. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti , 2000, Nature.
[41] S. Ghosh,et al. PDK1 Nucleates T Cell Receptor-Induced Signaling Complex for NF-κB Activation , 2005, Science.
[42] J. Keats,et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling , 2008, Nature Immunology.
[43] Georg Schett,et al. IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss , 2005, The Journal of experimental medicine.
[44] Ravi S. Misra,et al. Caspase-8 and c-FLIPL Associate in Lipid Rafts with NF-κB Adaptors during T Cell Activation* , 2007, Journal of Biological Chemistry.
[45] David Levens,et al. Ribosomal Protein S3: A KH Domain Subunit in NF-κB Complexes that Mediates Selective Gene Regulation , 2007, Cell.
[46] D. Raulet,et al. Development and selection of γδ T cells , 2007 .
[47] Zhijian J. Chen,et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK , 2001, Nature.
[48] F. Weih,et al. Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen. , 2007, Blood.
[49] J. Ruland,et al. Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications. , 2007, Blood.
[50] L. del Peso,et al. Nod1, an Apaf-1-like Activator of Caspase-9 and Nuclear Factor-κB* , 1999, The Journal of Biological Chemistry.
[51] T. Deerinck,et al. The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.
[52] R. Medzhitov,et al. Recognition of microbial infection by Toll-like receptors. , 2003, Current opinion in immunology.
[53] D. Rawlings,et al. Signaling in transitional type 2 B cells is critical for peripheral B‐cell development , 2004, Immunological reviews.
[54] Mitchell Kronenberg,et al. Toward an understanding of NKT cell biology: progress and paradoxes. , 2005, Annual review of immunology.
[55] Honglin Zhou,et al. Constitutive NF-kappaB activation by the t(11;18)(q21;q21) product in MALT lymphoma is linked to deregulated ubiquitin ligase activity. , 2005, Cancer cell.
[56] David A. Cheresh,et al. Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2007, Nature.
[57] Shizuo Akira,et al. Signaling to NF-?B by Toll-like receptors , 2007 .
[58] Ji-Yeon Kim,et al. Up-regulation of Cyclin D1 by HBx Is Mediated by NF-κB2/BCL3 Complex through κB Site of Cyclin D1 Promoter* , 2006, Journal of Biological Chemistry.
[59] N. Copeland,et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20 , 2008, Nature Immunology.
[60] F. Weih,et al. Differential Requirement for Rel/Nuclear Factor κB Family Members in Natural Killer T Cell Development , 2003, The Journal of experimental medicine.
[61] Jacques Neefjes,et al. Translocation of PKCθ in T cells is mediated by a nonconventional, PI3-K– and Vav-dependent pathway, but does not absolutely require phospholipase C , 2002, The Journal of cell biology.
[62] A. Weiss,et al. The PI‐3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3 , 2003, Immunological reviews.
[63] U. Siebenlist,et al. Control of lymphocyte development by nuclear factor-κB , 2005, Nature Reviews Immunology.
[64] H. Suyang,et al. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB , 1996 .
[65] Vishva M. Dixit,et al. IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis , 2007, Cell.
[66] Noula Shembade,et al. Essential role for TAX1BP1 in the termination of TNF‐α‐, IL‐1‐ and LPS‐mediated NF‐κB and JNK signaling , 2007 .
[67] D. Pellicci,et al. The Influence of CD1d in Postselection NKT Cell Maturation and Homeostasis1 , 2005, The Journal of Immunology.
[68] A. Israël,et al. Control of NF-κB Activity by the IκBβ Inhibitor , 1997 .
[69] G. Bishop,et al. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes. , 1997, Journal of immunology.
[70] A. Baldwin,et al. Members of the Nuclear Factor κB Family Transactivate the Murine c-myb Gene (*) , 1995, The Journal of Biological Chemistry.
[71] M. Mayo,et al. Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB , 2000, Molecular and Cellular Biology.
[72] I. Verma,et al. Immunological defects in mice with a targeted disruption in Bcl-3. , 1997, Genes & development.
[73] Zhijian J. Chen,et al. TRAF2: A Double-Edged Sword? , 2005, Science's STKE.
[74] J. Tschopp,et al. CARMA1 is a critical lipid raft–associated regulator of TCR-induced NF-κB activation , 2002, Nature Immunology.
[75] K. Rajewsky,et al. IκB Kinase Signaling Is Essential for Maintenance of Mature B Cells , 2002, The Journal of experimental medicine.
[76] G. Nabel,et al. A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription , 1997, Molecular and cellular biology.
[77] D. Goeddel,et al. TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90. , 2002, Molecular cell.
[78] T. Fujita,et al. TIR-containing Adapter Molecule (TICAM)-2, a Bridging Adapter Recruiting to Toll-like Receptor 4 TICAM-1 That Induces Interferon-β* , 2003, Journal of Biological Chemistry.
[79] F. Weih,et al. RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF , 2003, The EMBO journal.
[80] S. Ghosh,et al. Characterization of the IκB-kinase NEMO Binding Domain* , 2002, The Journal of Biological Chemistry.
[81] A. Israël,et al. Deciphering the pathway from the TCR to NF-κB , 2006, Cell Death and Differentiation.
[82] M. Mann,et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6 , 2006, Nature.
[83] Jürgen Ruland,et al. Transducing signals from antigen receptors to nuclear factor κB , 2003, Immunological reviews.
[84] Ronald T. Hay,et al. Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm , 1997 .
[85] V. Bours,et al. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers , 1993, Cell.
[86] F. Weih,et al. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.
[87] M. Reitz,et al. Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia , 1981, Nature.
[88] D. F. Barber,et al. NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. , 2000, Immunity.
[89] J. Bertin,et al. PYPAF7, a Novel PYRIN-containing Apaf1-like Protein That Regulates Activation of NF-κB and Caspase-1-dependent Cytokine Processing* , 2002, The Journal of Biological Chemistry.
[90] M. Seto,et al. Bcl10 and MALT1, Independent Targets of Chromosomal Translocation in MALT Lymphoma, Cooperate in a Novel NF-κB Signaling Pathway* , 2001, The Journal of Biological Chemistry.
[91] G. Courtois,et al. Mutations in the NF-κB signaling pathway: implications for human disease , 2006, Oncogene.
[92] A. Shevchenko,et al. Activation of Transcription Factor NF-κB Requires ELKS, an IκB Kinase Regulatory Subunit , 2004, Science.
[93] L. Staudt,et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. , 2002, The New England journal of medicine.
[94] T. Kaisho,et al. PDLIM2-mediated termination of transcription factor NF-κB activation by intranuclear sequestration and degradation of the p65 subunit , 2007, Nature Immunology.
[95] F. Weih,et al. Inhibition of NF‐κB in T cells blocks lymphoproliferation and partially rescues autoimmune disease in gld/gld mice , 2001, European journal of immunology.
[96] S. Akira,et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β , 2008, Nature Immunology.
[97] G. Widhopf,et al. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease. , 2006, Immunity.
[98] Douglas R. McDonald,et al. Selective predisposition to bacterial infections in IRAK-4–deficient children: IRAK-4–dependent TLRs are otherwise redundant in protective immunity , 2007, The Journal of experimental medicine.
[99] E. Reinherz,et al. Peptide-Induced Negative Selection of Thymocytes Activates Transcription of an NF-ΚB Inhibitor , 2002 .
[100] Michael Karin,et al. Intracellular pattern recognition receptors in the host response , 2006, Nature.
[101] A. Israël,et al. IκB proteins: structure, function and regulation , 1997 .
[102] R. Gaynor,et al. Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression , 2003, Nature.
[103] Ryuji Kobayashi,et al. IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a , 2004, Cell.
[104] C. Geisler,et al. Protein Kinase C (PKC)α and PKCθ Are the Major PKC Isotypes Involved in TCR Down-Regulation1 , 2006, The Journal of Immunology.
[105] M. Rowe,et al. Latent Membrane Protein 1 of Epstein-Barr Virus Stimulates Processing of NF-κB2 p100 to p52* , 2003, Journal of Biological Chemistry.
[106] A. Israël,et al. I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .
[107] Zhijian J. Chen. Ubiquitin signalling in the NF-κB pathway , 2005, Nature Cell Biology.
[108] S. Srinivasula,et al. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation , 2006, Nature Cell Biology.
[109] R. Hay,et al. βTrCP-Mediated Proteolysis of NF-κB1 p105 Requires Phosphorylation of p105 Serines 927 and 932 , 2003, Molecular and Cellular Biology.
[110] Michael U. Martin,et al. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. , 2002, Biochimica et biophysica acta.
[111] C. Scheidereit,et al. Shared Pathways of IκB Kinase-Induced SCFβTrCP-Mediated Ubiquitination and Degradation for the NF-κB Precursor p105 and IκBα , 2001, Molecular and Cellular Biology.
[112] R. Carmody,et al. Negative Regulation of Toll-Like Receptor Signaling by NF-κB p50 Ubiquitination Blockade , 2007, Science.
[113] R. Germain. T-cell development and the CD4–CD8 lineage decision , 2002, Nature Reviews Immunology.
[114] J. Cyster,et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. , 2004, Immunity.
[115] S. Akira,et al. TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway , 2003, Nature Immunology.
[116] M. Karin,et al. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction. , 1993, Genes & development.
[117] P. Farnham,et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. , 2004, Immunity.
[118] Shao-Cong Sun,et al. β-TrCP binding and processing of NF-κB2/p100 involve its phosphorylation at serines 866 and 870 , 2006 .
[119] T. Hope,et al. An N‐terminal nuclear export signal is required for the nucleocytoplasmic shuttling of IκBα , 1999 .
[120] J. Ninomiya-Tsuji,et al. IRAK-mediated Translocation of TRAF6 and TAB2 in the Interleukin-1-induced Activation of NFκB* , 2001, The Journal of Biological Chemistry.
[121] E. Cesarman,et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.
[122] Toby Lawrence,et al. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation , 2005, Nature.
[123] Zhaodan Cao,et al. TRAF6 is a signal transducer for interleukin-1 , 1996, Nature.
[124] S. Ghosh,et al. Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B , 1996, Molecular and cellular biology.
[125] J. Knop,et al. Effects of IL‐1 receptor‐associated kinase (IRAK) expression on IL‐1 signaling are independent of its kinase activity , 1999, FEBS letters.
[126] Tak W. Mak,et al. The role of nuclear factor-κB essential modulator (NEMO) in B cell development and survival , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[127] Ralf Bartenschlager,et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus , 2005, Nature.
[128] Zhijian J. Chen,et al. Ubiquitination and TRAF signaling. , 2007, Advances in experimental medicine and biology.
[129] David Baltimore,et al. Multiple nuclear factors interact with the immunoglobulin enhancer sequences , 1986, Cell.
[130] D. Lo,et al. Expression of relB is required for the development of thymic medulla and dendritic cells , 1995, Nature.
[131] N. Perkins. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway , 2006, Oncogene.
[132] L. Scorrano,et al. Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-κB and NFAT , 2001, Nature Immunology.
[133] N. Gay,et al. Structural Complementarity of Toll/Interleukin-1 Receptor Domains in Toll-like Receptors and the Adaptors Mal and MyD88* , 2003, Journal of Biological Chemistry.
[134] O. Lantz,et al. Lineage Relationships and Differentiation of Natural Killer (NK) T Cells: Intrathymic Selection and Interleukin (IL)-4 Production in the Absence of NKR-P1 and Ly49 Molecules , 1997, The Journal of experimental medicine.
[135] H. Igarashi,et al. Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. , 2005, International immunology.
[136] S. Ghosh,et al. Shared Principles in NF-κB Signaling , 2008, Cell.
[137] M. Karin. Nuclear factor-κB in cancer development and progression , 2006, Nature.
[138] D. Goeddel,et al. TNF-R1 Signaling: A Beautiful Pathway , 2002, Science.
[139] Gabriel Pineda,et al. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. , 2006, Molecular cell.
[140] J. Tschopp,et al. Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.
[141] Xiaojing Ma,et al. Interferon Regulatory Factor 8 Regulates RANTES Gene Transcription in Cooperation with Interferon Regulatory Factor-1, NF-κB, and PU.1* , 2006, Journal of Biological Chemistry.
[142] W. Liao,et al. The essential role of MEKK3 in TNF-induced NF-κB activation , 2001, Nature Immunology.
[143] L. Tong,et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains , 2000, Nature.
[144] P. Lucas,et al. A critical role of RICK/RIP2 polyubiquitination in Nod‐induced NF‐κB activation , 2008 .
[145] M. Turner,et al. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[146] I. Verma,et al. Phosphorylation of SNAP-23 by IκB Kinase 2 Regulates Mast Cell Degranulation , 2008, Cell.
[147] G. Cheng,et al. Rescue of TRAF3-null mice by p100 NF-κB deficiency , 2006, The Journal of experimental medicine.
[148] Ming-Qing Du,et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy , 2001, The Lancet.
[149] B. Aronow,et al. Activation of IKKα target genes depends on recognition of specific κB binding sites by RelB:p52 dimers , 2004 .
[150] G. Courtois,et al. Posttranslational modifications of NEMO and its partners in NF-κB signaling , 2006 .
[151] J. Orange,et al. Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations , 2002 .
[152] M. Kelliher,et al. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. , 2000, Immunity.
[153] Claus Scheidereit,et al. NF-κB Function in Growth Control: Regulation of Cyclin D1 Expression and G0/G1-to-S-Phase Transition , 1999, Molecular and Cellular Biology.
[154] L. Young,et al. LMP1 structure and signal transduction. , 2001, Seminars in cancer biology.
[155] F. Weih,et al. RelB-Dependent Stromal Cells Promote T-Cell Leukemogenesis , 2008, PloS one.
[156] S. Yamaoka,et al. Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.
[157] B. Dörken,et al. Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed-Sternberg cells , 1999, Oncogene.
[158] V. Bours,et al. The oncoprotein Bcl‐3 can facilitate NF‐kappa B‐mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. , 1993, The EMBO journal.
[159] T. Serikawa,et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase , 1999, Nature Genetics.
[160] B. Seed,et al. RIP mediates tumor necrosis factor receptor 1 activation of NF‐kappaB but not Fas/APO‐1‐initiated apoptosis. , 1996, The EMBO journal.
[161] Hong-Bing Shu,et al. TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.
[162] Minoru Yoshida,et al. A nuclear export signal in the N-terminal regulatory domain of IκBα controls cytoplasmic localization of inactive NF-κB/IκBα complexes , 2000 .
[163] A. Rabson,et al. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes , 2000, Oncogene.
[164] Hana Kim,et al. A Fourth IκB Protein within the NF-κB Signaling Module , 2007, Cell.
[165] D. Baltimore,et al. The NF‐kappa B p50 precursor, p105, contains an internal I kappa B‐like inhibitor that preferentially inhibits p50. , 1992, The EMBO journal.
[166] D. Carrasco,et al. Gastric Hyperplasia and Increased Proliferative Responses of Lymphocytes in Mice Lacking the COOH-terminal Ankyrin Domain of NF-κB2 , 1997, The Journal of experimental medicine.
[167] Albert Bendelac,et al. The biology of NKT cells. , 2007, Annual review of immunology.
[168] J. Pober,et al. Tumor necrosis factor receptor-associated factors (TRAFs) , 2001, Oncogene.
[169] D. Goeddel,et al. The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis , 2003, The Journal of experimental medicine.
[170] G. Hortobagyi,et al. IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway , 2007, Cell.
[171] Liming Yang,et al. A loss-of-function RNA interference screen for molecular targets in cancer , 2006, Nature.
[172] J. Inoue,et al. Identification of TIFA as an Adapter Protein That Links Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) to Interleukin-1 (IL-1) Receptor-associated Kinase-1 (IRAK-1) in IL-1 Receptor Signaling* , 2003, The Journal of Biological Chemistry.
[173] F. Martinon,et al. RIP1 is an essential mediator of Toll-like receptor 3–induced NF-κB activation , 2004, Nature Immunology.
[174] I. Screpanti,et al. Notch3 and pre‐TCR interaction unveils distinct NF‐κB pathways in T‐cell development and leukemia , 2006, The EMBO journal.
[175] David L. Vaux,et al. IAPs, RINGs and ubiquitylation , 2005, Nature Reviews Molecular Cell Biology.
[176] T. Mak,et al. Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. , 2000, Genes & development.
[177] E. Schaeffer,et al. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes , 2000, Nature.
[178] Ramin Massoumi,et al. Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling , 2006, Cell.
[179] F. Weih,et al. Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines1 , 2001, The Journal of Immunology.
[180] D. Baltimore,et al. The combined absence of the transcription factors Rel and RelA leads to multiple hemopoietic cell defects. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[181] J. Caamaño,et al. Epstein–Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-κB2 to p52 via an IKKγ/NEMO-independent signalling pathway , 2003, Oncogene.
[182] Sokol Haxhinasto,et al. Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)-deficient B Lymphocytes Reveal Novel Roles for TRAF2 in CD40 Signaling* , 2003, Journal of Biological Chemistry.
[183] M. Neuenhahn,et al. NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβ , 2007, Cell.
[184] D. Thomas,et al. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. , 1997, Journal of cell science.
[185] A. Rao,et al. Degradation of Bcl10 Induced by T-Cell Activation Negatively Regulates NF-κB Signaling , 2004, Molecular and Cellular Biology.
[186] P. Evans,et al. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. , 2008, The Journal of biological chemistry.
[187] V. Dötsch,et al. Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins , 2008, Oncogene.
[188] M. Busslinger. Transcriptional control of early B cell development. , 2004, Annual review of immunology.
[189] K. Todokoro,et al. Isolation of a Novel Interleukin-1-inducible Nuclear Protein Bearing Ankyrin-repeat Motifs* , 2001, The Journal of Biological Chemistry.
[190] L. Pham,et al. Nuclear Localization in the Biology of the CD40 Receptor in Normal and Neoplastic Human B Lymphocytes* , 2006, Journal of Biological Chemistry.
[191] M. Teitell,et al. PKC-β controls IκB kinase lipid raft recruitment and activation in response to BCR signaling , 2002, Nature Immunology.
[192] X. Mao,et al. COMMD1 promotes the ubiquitination of NF‐κB subunits through a cullin‐containing ubiquitin ligase , 2007, The EMBO journal.
[193] F. Mackay,et al. TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. , 2008, Immunity.
[194] V. Godfrey,et al. Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. , 2000, Molecular cell.
[195] S. Park,et al. Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.
[196] M. Busslinger,et al. Pax5: the guardian of B cell identity and function , 2007, Nature Immunology.
[197] David L. Vaux,et al. IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis , 2007, Cell.
[198] G. Bren,et al. RelB Cellular Regulation and Transcriptional Activity Are Regulated by p100* , 2002, The Journal of Biological Chemistry.
[199] P. Dobrzanski,et al. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. , 1995, Oncogene.
[200] K. Jeang,et al. Coiled-coil motif as a structural basis for the interaction of HTLV type 1 Tax with cellular cofactors. , 2000, AIDS research and human retroviruses.
[201] Yukio Nakamura,et al. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts , 1999, Oncogene.
[202] C. Bakal,et al. The Molecular Adapter Carma1 Controls Entry of IκB Kinase into the Central Immune Synapse , 2004, The Journal of experimental medicine.
[203] Gabriel Núñez,et al. Intracellular NOD-like receptors in host defense and disease. , 2007, Immunity.
[204] R. Chaganti,et al. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50 , 1991, Cell.
[205] G. Bishop. The multifaceted roles of TRAFs in the regulation of B-cell function , 2004, Nature Reviews Immunology.
[206] Michael Karin,et al. Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.
[207] David M. Rothwarf,et al. The NF-κB Activation Pathway: A Paradigm in Information Transfer from Membrane to Nucleus , 1999, Science's STKE.
[208] Tom Maniatis,et al. The ubiquitinproteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB , 1994, Cell.
[209] C. Turck,et al. Akt-Dependent Phosphorylation Specifically Regulates Cot Induction of NF-κB-Dependent Transcription , 2002, Molecular and Cellular Biology.
[210] B. Dörken,et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. , 1997, The Journal of clinical investigation.
[211] Carey L. Medin,et al. Functional Characterization of Murine Interferon Regulatory Factor 5 (IRF-5) and Its Role in the Innate Antiviral Response* , 2008, Journal of Biological Chemistry.
[212] Zhijian J. Chen,et al. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. , 2004, Molecular cell.
[213] Zhijian J. Chen,et al. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. , 2004, Molecular cell.
[214] R. Beyaert,et al. Yeast two-hybrid screening for proteins interacting with the anti-apoptotic protein A20. , 2004, Methods in molecular biology.
[215] K. Ishii,et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling , 2006, Nature Immunology.
[216] V. Diehl,et al. Part I: Hodgkin's lymphoma--molecular biology of Hodgkin and Reed-Sternberg cells. , 2004, The Lancet. Oncology.
[217] M. Karin,et al. IκB kinase-α acts in the epidermis to control skeletal and craniofacial morphogenesis , 2004, Nature.
[218] H. Stein,et al. Elevated NF-κB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas , 2005 .
[219] John Bertin,et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island , 2004, Nature Immunology.
[220] S. Gaffen,et al. CD3/CD28 Costimulation-Induced NF-κB Activation Is Mediated by Recruitment of Protein Kinase C-θ, Bcl10, and IκB Kinase β to the Immunological Synapse through CARMA1 , 2004, Molecular and Cellular Biology.
[221] F. Weih,et al. Mice lacking the transcription factor RelB develop T cell‐dependent skin lesions similar to human atopic dermatitis , 2000, European journal of immunology.
[222] H. Erdjument-Bromage,et al. IκB-β regulates the persistent response in a biphasic activation of NF-κB , 1995, Cell.
[223] J. Hiscott. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. , 2007, Cytokine & growth factor reviews.
[224] G. Bishop,et al. Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. , 2007, Immunity.
[225] J. Caamaño,et al. Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo , 1996, Molecular and cellular biology.
[226] A. Ashworth,et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.
[227] R. Eisenberg,et al. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. , 1991, Annual review of immunology.
[228] M. Merville,et al. Protein Phosphorylation as a Key Mechanism for the Regulation of BCL-3 Activity , 2004, Cell cycle.
[229] M. Busslinger,et al. Lack of nuclear factor-kappa B2/p100 causes a RelB-dependent block in early B lymphopoiesis. , 2008, Blood.
[230] Somasekar Seshagiri,et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling , 2004, Nature.
[231] P. Cohen,et al. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. , 2007, The Biochemical journal.
[232] J. Bertin,et al. Sensing intracellular pathogens-NOD-like receptors. , 2008, Current opinion in pharmacology.
[233] J. Mizukami,et al. TAK1-TAB1 fusion protein: a novel constitutively active mitogen-activated protein kinase kinase kinase that stimulates AP-1 and NF-kappaB signaling pathways. , 2002, Biochemical and biophysical research communications.
[234] G. Cheng,et al. Control of canonical NF-κB activation through the NIK–IKK complex pathway , 2008, Proceedings of the National Academy of Sciences.
[235] G. Mosialos,et al. p105, the NF-kappa B p50 precursor protein, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells , 1992, Journal of virology.
[236] A. Israël,et al. T-cell-receptor- and B-cell-receptor-mediated activation of NF-κB in lymphocytes , 2004 .
[237] S. Westerheide,et al. The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition , 2001, Molecular and Cellular Biology.
[238] A. Duncan,et al. Pleiotropic defects in TCR signaling in a Vav‐1‐null Jurkat T‐cell line , 2002, The EMBO journal.
[239] Xiaolu Yang,et al. Cellular Inhibitor of Apoptosis 1 and 2 Are Ubiquitin Ligases for the Apoptosis Inducer Smac/DIABLO* , 2003, The Journal of Biological Chemistry.
[240] E. Harhaj,et al. Retroviral oncoprotein Tax induces processing of NF‐κB2/p100 in T cells: evidence for the involvement of IKKα , 2001 .
[241] A. Borsetti,et al. Terminal Repeat Enhancer Immunodeficiency Virus Type 1 Long Transcriptional Activity at the Human B Κ Irf-1 Is Required for Full Nf , 2007 .
[242] E. Cesarman,et al. Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.
[243] A. Israël,et al. Induction of the NF-κB Cascade by Recruitment of the Scaffold Molecule NEMO to the T Cell Receptor , 2003 .
[244] S. Akira,et al. Essential function for the kinase TAK1 in innate and adaptive immune responses , 2005, Nature Immunology.
[245] Michael Karin,et al. Regulation and Function of IKK and IKK-Related Kinases , 2006, Science's STKE.
[246] Zheng‐gang Liu,et al. The function of TRADD in signaling through tumor necrosis factor receptor 1 and TRIF-dependent Toll-like receptors , 2008, Nature Immunology.
[247] G. Nolan,et al. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers. , 1993, Genes & development.
[248] I. Verma,et al. Distinct roles of IκB proteins in regulating constitutive NF-κB activity , 2005, Nature Cell Biology.
[249] Claus Scheidereit,et al. IκB kinase complexes: gateways to NF-κB activation and transcription , 2006, Oncogene.
[250] M. Mayo,et al. IκB Kinase α-Mediated Derepression of SMRT Potentiates Acetylation of RelA/p65 by p300 , 2006, Molecular and Cellular Biology.
[251] Z. Ye,et al. ATP Binding by Monarch-1/NLRP12 Is Critical for Its Inhibitory Function , 2007, Molecular and Cellular Biology.
[252] I. Verma,et al. NF-κB regulation in the immune system , 2002, Nature Reviews Immunology.
[253] J. Ashwell,et al. Lys63-Linked Polyubiquitination of IRAK-1 Is Required for Interleukin-1 Receptor- and Toll-Like Receptor-Mediated NF-κB Activation , 2008, Molecular and Cellular Biology.
[254] B. Liu,et al. Control of specificity and magnitude of NF-κB and STAT1-mediated gene activation through PIASy and PIAS1 cooperation , 2007, Proceedings of the National Academy of Sciences.
[255] Honglin Zhou,et al. Bcl10 activates the NF-κB pathway through ubiquitination of NEMO , 2004, Nature.
[256] S. Ley,et al. Functions of NF-?B1 and NF-?B2 in immune cell biology , 2004 .
[257] G. Courtois,et al. NF-κB Defects in Humans: The NEMO/Incontinentia Pigmenti Connection , 2000, Science's STKE.
[258] G. Kroemer,et al. Targeting NF-κB in hematologic malignancies , 2006, Cell Death and Differentiation.
[259] B. Dörken,et al. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. , 1996, Blood.
[260] M. Siekevitz,et al. Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NF kappa B. , 1992, The Journal of biological chemistry.
[261] E. Schmidt,et al. IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development , 2001, Cell.
[262] M. Xie,et al. Persistent Activation of NF-κB by the Tax Transforming Protein Involves Chronic Phosphorylation of IκB Kinase Subunits IKKβ and IKKγ* , 2001, The Journal of Biological Chemistry.
[263] R. Schmid,et al. Rel/NF‐κB family member RelA regulates NK1.1− to NK1.1+ transition as well as IL‐15‐induced expansion of NKT cells , 2008, European journal of immunology.
[264] D. Wallach,et al. MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.
[265] M. Schebesta,et al. Transcriptional control of B-cell development. , 2002, Current opinion in immunology.
[266] E. Harhaj,et al. Regulation of the NF-κB-inducing Kinase by Tumor Necrosis Factor Receptor-associated Factor 3-induced Degradation* , 2004, Journal of Biological Chemistry.
[267] T. Muta,et al. Crucial roles of binding sites for NF-κB and C/EBPs in IκB-ζ-mediated transcriptional activation , 2007 .
[268] Chun Chia Chen,et al. Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-κB-induced CCAAT/enhancer-binding protein δ in mouse macrophages , 2006 .
[269] Qiang Sun,et al. The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways , 2007, Nature Immunology.
[270] K. M. Bendt,et al. LMP1 signaling and activation of NF-κB in LMP1 transgenic mice , 2006, Oncogene.
[271] H. Kuwata,et al. IkappaBNS inhibits induction of a subset of Toll-like receptor-dependent genes and limits inflammation. , 2006, Immunity.
[272] A. Ryo,et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.
[273] K. Irie,et al. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. , 2000, Molecular cell.
[274] M. Karin,et al. Essential Cytoplasmic Translocation of a Cytokine Receptor–Assembled Signaling Complex , 2008, Science.
[275] Hiroshi Yasui,et al. MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth In vitro and In vivo , 2006, Clinical Cancer Research.
[276] F. Real,et al. Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancer , 2007, Proceedings of the National Academy of Sciences.
[277] C. Ware,et al. The unconventional role of LTαβ in T cell differentiation , 2007 .
[278] G Cantarella,et al. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation. , 2000, Immunity.
[279] Steve Gerondakis,et al. The anti‐apoptotic activities of Rel and RelA required during B‐cell maturation involve the regulation of Bcl‐2 expression , 2000, The EMBO journal.
[280] C. Scheidereit,et al. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[281] M. Teitell,et al. Negative Regulation of NF-κB Signaling by PIAS1 , 2005, Molecular and Cellular Biology.
[282] N. Gay,et al. Trif-related adapter molecule is phosphorylated by PKC{epsilon} during Toll-like receptor 4 signaling. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[283] C. Hsieh,et al. Regulation of LPS-mediated induction of C/EBPδ gene expression in livers of young and aged mice , 1998 .
[284] C. Scheidereit,et al. The NF‐kappa B precursor p105 and the proto‐oncogene product Bcl‐3 are I kappa B molecules and control nuclear translocation of NF‐kappa B. , 1993, The EMBO journal.
[285] A. Shahangian,et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response , 2006, Nature.
[286] D. Goeddel,et al. Defective Lymphotoxin-β Receptor-Induced NF-κB Transcriptional Activity in NIK-Deficient Mice , 2001, Science.
[287] Michael Karin,et al. NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.
[288] J. Skok,et al. Transcriptional regulation in early B cell development. , 2007, Current opinion in immunology.
[289] U. Lendahl,et al. Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice , 2000, The EMBO journal.
[290] L. Cantley,et al. The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMO , 2004, Current Biology.
[291] D. Green,et al. The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .
[292] C. Sedwick,et al. Perspectives on PKCtheta in T cell activation. , 2004, Molecular immunology.
[293] G. Natoli,et al. Nuclear Ubiquitin Ligases, NF-κB Degradation, and the Control of Inflammation , 2008, Science Signaling.
[294] B. Huhse,et al. CD40 regulates the processing of NF‐κB2 p100 to p52 , 2002 .
[295] K. Ebner,et al. GMCSF activates NF-κB via direct interaction of the GMCSF receptor with IκB kinase β , 2003 .
[296] A. Neri,et al. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators , 1995, Molecular and cellular biology.
[297] W C Greene,et al. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. , 1993, Science.
[298] David F. Kashatus,et al. Expression of the Bcl-3 proto-oncogene suppresses p53 activation. , 2006, Genes & development.
[299] M. Eby,et al. The Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein Physically Associates with and Persistently Activates the IκB Kinase Complex* , 2002, The Journal of Biological Chemistry.
[300] M. Matsumoto,et al. Abnormal Immune Function of Hemopoietic Cells from Alymphoplasia (aly) Mice, a Natural Strain with Mutant NF-κB-Inducing Kinase1 , 2000, The Journal of Immunology.
[301] G. Courtois,et al. The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.
[302] David Allman,et al. Regulation of peripheral B cell maturation. , 2006, Cellular immunology.
[303] R. Hay,et al. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IκBα , 1999, Oncogene.
[304] Eric Verdin,et al. Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.
[305] A. Hoffmann,et al. Transcriptional regulation via the NF-κB signaling module , 2006, Oncogene.
[306] A. Israël,et al. NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. , 1996, Development.
[307] M. Karin,et al. ReviewMissing Pieces in the NF-B Puzzle stimulate the migration and maturation of lymphocytes , 2002 .
[308] G. Cheng,et al. Specificity of TRAF3 in Its Negative Regulation of the Noncanonical NF-κB Pathway* , 2006, Journal of Biological Chemistry.
[309] L. Pham,et al. Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma. , 2007, Blood.
[310] M. Karin,et al. IKKα controls formation of the epidermis independently of NF-κB , 2001, Nature.
[311] S. Akira,et al. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[312] T. Saitoh,et al. TWEAK Induces NF-κB2 p100 Processing and Long Lasting NF-κB Activation* , 2003, Journal of Biological Chemistry.
[313] T. Gilmore. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel , 1999, Oncogene.
[314] Zhonghe Zhou,et al. The smallest known non-avian theropod dinosaur , 2000, Nature.
[315] T. Mak,et al. Activation of noncanonical NF-κB requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, TRAF3 and the kinase NIK , 2008, Nature Immunology.
[316] S. Gerondakis,et al. Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.
[317] Shizuo Akira,et al. TIR domain-containing adaptors regulate TLR signaling pathways. , 2005, Advances in experimental medicine and biology.
[318] M. Kehry,et al. CD40 Signaling through Tumor Necrosis Factor Receptor-associated Factors (TRAFs) , 1999, The Journal of Biological Chemistry.
[319] R. Gaynor,et al. I-κB Kinases α and β Have Distinct Roles in Regulating Murine T Cell Function1 , 2002, The Journal of Immunology.
[320] T. Banks,et al. NIK-dependent RelB Activation Defines a Unique Signaling Pathway for the Development of Vα14i NKT Cells , 2003, The Journal of experimental medicine.
[321] A. Hayday,et al. Lymphotoxin-Mediated Regulation of γδ Cell Differentiation by αß T Cell Progenitors , 2005, Science.
[322] L. Bruhn,et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. , 2007, Cancer cell.
[323] T. Phan,et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. , 2004, Immunity.
[324] R. Maehr,et al. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[325] R. Brink,et al. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. , 2004, Immunity.
[326] Michael D. Schneider,et al. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function , 2006, Nature Immunology.
[327] Alexander Hoffmann,et al. Stimulus Specificity of Gene Expression Programs Determined by Temporal Control of IKK Activity , 2005, Science.